Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![SamFazeli8 Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1180123356403834880.png) Sam Fazeli [@SamFazeli8](/creator/twitter/SamFazeli8) on x 2717 followers
Created: 2025-07-07 08:50:45 UTC

$RPRX $RVMD What Does Royalty Pharma's Revolution Medicine Deal Tell us About The Emerging KRAS-Addicted Cancer Market? Our modelling suggests that for the deal to work for $RPRX, the XX year cumulative sales of daraxonrasib  need to reach $XX billion:


XXXXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1942144244690677773/c:line.svg)

**Related Topics**
[$rprx](/topic/$rprx)
[$rvmd](/topic/$rvmd)

[Post Link](https://x.com/SamFazeli8/status/1942144244690677773)

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

SamFazeli8 Avatar Sam Fazeli @SamFazeli8 on x 2717 followers Created: 2025-07-07 08:50:45 UTC

$RPRX $RVMD What Does Royalty Pharma's Revolution Medicine Deal Tell us About The Emerging KRAS-Addicted Cancer Market? Our modelling suggests that for the deal to work for $RPRX, the XX year cumulative sales of daraxonrasib need to reach $XX billion:

XXXXX engagements

Engagements Line Chart

Related Topics $rprx $rvmd

Post Link

post/tweet::1942144244690677773
/post/tweet::1942144244690677773